1. Home
  2. VALN vs CDNA Comparison

VALN vs CDNA Comparison

Compare VALN & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$10.30

Market Cap

855.8M

Sector

Health Care

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$20.49

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VALN
CDNA
Founded
2012
1998
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
855.8M
1.0B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
VALN
CDNA
Price
$10.30
$20.49
Analyst Decision
Strong Buy
Buy
Analyst Count
4
7
Target Price
$15.75
$26.67
AVG Volume (30 Days)
19.5K
723.7K
Earning Date
11-20-2025
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.22
Revenue
$211,089,992.00
$357,998,000.00
Revenue This Year
$3.64
$14.47
Revenue Next Year
$12.23
$11.35
P/E Ratio
N/A
$16.81
Revenue Growth
13.48
14.46
52 Week Low
$4.56
$10.96
52 Week High
$12.25
$25.55

Technical Indicators

Market Signals
Indicator
VALN
CDNA
Relative Strength Index (RSI) 54.28 56.46
Support Level $9.62 $19.48
Resistance Level $10.32 $21.49
Average True Range (ATR) 0.30 1.18
MACD 0.03 0.09
Stochastic Oscillator 62.50 76.57

Price Performance

Historical Comparison
VALN
CDNA

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: